Other languages Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Market Closed - Australian S.E. Other stock markets 02:10:45 2024-04-19 am EDT			5-day change	1st Jan Change
13.61 ^AUD	-0.80%		+5.26%	+35.02%

Apr. 18	Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 from AU$13.27, Keeps at Buy	MT
Apr. 17	Telix Pharmaceuticals Limited Reports Unaudited Revenue Results for the First Quarter Ended 31 March 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Telix Pharmaceuticals Limited Reaffirms Revenue Guidance for the Year 2024	Apr. 17
Telix Pharmaceuticals Logs Nearly $115 Million Revenue in Q1	Apr. 17
Telix Pharmaceuticals Limited Announces FDA Fast Track Designation for TLX101-CDx	Apr. 15
Telix Pharmaceuticals Limited schließt die Übernahme von ARTMS, Inc. ab.	Apr. 11
Telix Pharmaceuticals Limited completa la adquisición de ARTMS Inc.	Apr. 11
Telix Pharmaceuticals Completes Acquisition of Canadian Firm ARTMS	Apr. 11
Telix Pharmaceuticals Limited completed the acquisition of ARTMS, INC.	Apr. 10
Telix Pharmaceuticals Completes Acquisition of IsoTherapeutics Group	Apr. 08
Telix Pharmaceuticals Limited completed the acquisition of IsoTherapeutics Group, LLC for $8.1 million.	Apr. 08
Telix Pharmaceuticals Limited Announces First Patient Dosed in Italian Named Patient ( Early Access) Program for TLX250-CDx Telix's Kidney Cancer Imaging Agent	Mar. 25
Telix Pharmaceuticals Appoints Group COO; Shares Down 4%	Mar. 11
Telix Pharmaceuticals to Buy Canadian Radioisotope Production Firm ARTMS	Mar. 04
Telix Pharmaceuticals Jumps 7% on IsoTherapeutics Group Acquisition Deal	Feb. 26
Telix Pharmaceuticals Posts 214% Surge in FY23 Revenue; Returns to Profit	Feb. 22
Telix Pharmaceuticals Limited Provides Earnings Guidance for Full Year Revenue 2024	Feb. 22
Telix Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22
Telix Pharmaceuticals to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform	Feb. 07
Australia shares led higher by Financials; US inflation in focus	Jan. 10
Australia's Telix Pharmaceuticals jumps on potential US listing	Jan. 04
Telix Pharmaceuticals Mulls US IPO	Jan. 04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Other languages

Filters